Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. antigen assay
Show results for
Products

Companies

News
Articles
Videos

Refine by
Date

  • Older

Antigen Assay Articles & Analysis

17 news found

Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

Creative Diagnostics Launches Human Hybrid IgM Control Monoclonal Antibodies to Accelerate Diagnostic Assay Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with ...

ByCreative Diagnostics


Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the expansion of its Hepatitis B research portfolio with a comprehensive range of sensitive and specific Hepatitis B Virus Surface Antigen L-proteins. ...

ByCreative Diagnostics


H5N1 Antibodies and Antigens for Research Applications

H5N1 Antibodies and Antigens for Research Applications

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is excited to announce the launch of its new line of H5N1 Antibodies and Antigens to support cutting-edge research on this highly pathogenic influenza A virus subtype. ...

ByCreative Diagnostics


Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its highly specific Anti-Adenovirus Monoclonal Antibody. ...

ByCreative Diagnostics


Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its extensive portfolio of P53 and TP53 antibodies and solutions to support researchers in the critical field of cancer research. ...

ByCreative Diagnostics


Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). ...

ByCreative Diagnostics


Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research

Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies. ...

ByCreative Diagnostics


Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Scientists from Creative Diagnostics can also work with clients to prevent early pitfalls with assay development by assessing the purposes and desired attributes of the assay while adhering to strict quality control guidelines from start to finish. Creative Diagnostics focuses on thorough optimization and validation of every aspect of assay ...

ByCreative Diagnostics


Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers

Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers

Meanwhile, monoclonal antibodies have monovalent affinity and can only recognize the same epitope of an antigen. Monoclonal antibodies are commonly used as primary antibodies in immunoassays because of their ability to specifically bind a single epitope of an antigen. ...

ByCreative Diagnostics


Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics' monkeypox virus antigens are expressed in E. coli or HEK293 cells and are manufactured at a purity level of > 90%, suitable for ELISA and lateral flow assays and can be used to develop diagnostic assays. ...

ByCreative Diagnostics


NCI and rutgers university open phase 1 clinical trials of t cell receptor therapy targeting KK-LC-1for multiple solid tumors

NCI and rutgers university open phase 1 clinical trials of t cell receptor therapy targeting KK-LC-1for multiple solid tumors

” Patients entering the trial are selected based on their expression of the KK-LC-1 antigen as determined by an immunohistochemistry assay. This assay was developed by T-Cure and validated for use in the ongoing trials. ...

ByT-Cure BioScience, Inc.


Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support MPXV Research

These antigens and antibodies can be used for scientific research and the detection of SARS-CoV-2-specific antibodies. ...

ByCreative Diagnostics


Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). ...

ByCreative Diagnostics


Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Laboratory detection of NiV can be performed using real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Creative Diagnostics now expands its portfolio and releases a series of NiV recombinant antigen and antibody pairs for research use. ...

ByCreative Diagnostics


Obsidian Therapeutics to Present Preclinical Data from cytoTIL15™ Program at the American Associate of Cancer Research (AACR) Annual Meeting 2022

Obsidian Therapeutics to Present Preclinical Data from cytoTIL15™ Program at the American Associate of Cancer Research (AACR) Annual Meeting 2022

The data to be presented demonstrate significantly greater anti-tumor activity of cytoTIL15 therapy in vivo compared to conventional TIL + IL2 therapy in a human leukocyte antigen (HLA)-matched, allogeneic patient-derived xenograft (PDX) melanoma model, including greater persistence of cytoTIL15 cells in blood and lymphoid organs, superior tumor growth inhibition including ...

ByObsidian Therapeutics, Inc.


Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens that are well validated in double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). ...

ByCreative Diagnostics


Obsidian Therapeutics to Present In Vivo Anti-TumorEfficacy Data from Novel Engineered cytoTIL15 Program at SITC 2021

Obsidian Therapeutics to Present In Vivo Anti-TumorEfficacy Data from Novel Engineered cytoTIL15 Program at SITC 2021

Obsidian Therapeutics designed genetically engineered TILs to express a regulated form of membrane-bound IL15 for tunable long-term persistence, leading to enhanced persistence and efficacy in vitro and in PDX tumor models. cytoTIL15 TILs demonstrated enhanced potency over conventional TILs in vitro, and persisted without IL2 at greater frequencies compared to conventional TILs + IL2 in a 10-day ...

ByObsidian Therapeutics, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT